AGL
Agilon Health, Inc.
AGL lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
AGL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Unavailable |
AGL's revenue and profitability are currently stable, but its cash flow is under pressure. There isn't enough data to rate its balance sheet.
AGL PE Valuation
AGL has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 64x next year's earnings.
AGL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AGL to return to profit, with revenue growing. However, they disagree widely on these estimates.
AGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.72 | — |
| Q3 2026 | -$5.46 | +$13.21 |
| Q2 2026 | -$14.08 | +$5.09 |
| Q1 2026 | -$21.43 | -$6.70 |
| Q4 2025 | -$23.63 | -$7.80 |
| Q3 2025 | -$18.67 | +$4.76 |
| Q2 2025 | -$19.17 | -$0.88 |
| Q1 2025 | -$14.73 | +$2.69 |
| Q4 2024 | -$15.83 | +$0.22 |
AGL is still losing money, but far less than before: $5.46 per share over the past year, against $27.25 at its worst in late 2021.
AGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +5.9% |
| Q2 2026 | $1.5B | +7.2% |
| Q1 2026 | $1.4B | -7.3% |
| Q4 2025 | $1.6B | +3.1% |
| Q3 2025 | $1.4B | -1.1% |
| Q2 2025 | $1.4B | -5.9% |
| Q1 2025 | $1.5B | -4.5% |
| Q4 2024 | $1.5B | +87% |
AGL's revenue grew through 2024 and has held roughly level since: $1.5B last quarter, up 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +11 points |
| Q2 2026 | 0.8% | +9.1 points |
| Q1 2026 | 0.3% | +1.7 points |
| Q4 2025 | -12% | -5.3 points |
| Q3 2025 | -9.2% | 0 points |
| Q2 2025 | -8.3% | -5.4 points |
| Q1 2025 | -1.4% | -1 points |
| Q4 2024 | -7.1% | +13 points |
AGL's operating margin was 1.6% last quarter, up 11 points from the same quarter a year ago, near the top of its range since 2020.
AGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $46.6M | +$67.9M |
| Q2 2026 | -$60.7M | -$22.4M |
| Q1 2026 | $20.6M | +$56.5M |
| Q4 2025 | -$23.5M | -279% |
| Q3 2025 | -$21.3M | -$10.1M |
| Q2 2025 | -$38.3M | -$16.3M |
| Q1 2025 | -$35.8M | +$15.1M |
| Q4 2024 | $13.2M | +$78.3M |
AGL has burned cash in almost every quarter: −$17M over the past year, against −$82M the year before.
AGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.8% | +475K shares |
| 1 year | +6.7% | +1.1M shares |
| 3 years | +9% | +1.5M shares |
| 5 years | +13% | +2M shares |
| Available history | +15% | +2.3M shares |
AGL has 18M diluted shares, up 6.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2021 | — |
| Q1 2021 | — |
| Q3 2020 | $6.7M |
| Q2 2020 | — |
AGL Net Leverage
AGL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 58.3 | Neutral |
AGL's weekly RSI is 64 (neutral) and its Stochastic is 58 (neutral).
AGL PE vs Healthcare Sector
AGL has no meaningful PE right now: it lost money over the past year.
AGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $91.3 | 21% above |
| 20 week MA | $96.3 | 15% above |
| 50 week MA | $61.7 | 79% above |
| 100 week MA | $59.8 | 85% above |
| 200 week MA | $181.6 | 39% below |
AGL has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 39% below its 200-week average.
AGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $750.0 | $684.8 | -8.7% |
| 2022 | $684.8 | $407.0 | -41% |
| 2023 | $407.0 | $313.8 | -23% |
| 2024 | $313.8 | $47.5 | -85% |
| 2025 | $47.5 | $18.2 | -62% |
| 2026 YTD | $18.2 | $110.3 | +508% |
AGL has finished every year since 2021 lower, and it's up 508% so far in 2026.